(Q35090016)

6 August 2017

1 reference

title

Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain (English)

1 reference

6 August 2017

1 reference

1 reference

Francisella tularensis

object named as

Francisella tularensis

1 reference

Karen L Elkins

1

1 reference

PubMed ID

12650771

6 August 2017

Siobhán C Cowley

series ordinal

2

1 reference

PubMed ID

12650771

6 August 2017

Catharine M Bosio

series ordinal

3

1 reference

6 August 2017

1 February 2003

1 reference

6 August 2017

Microbes and Infection

1 reference

6 August 2017

5

1 reference

6 August 2017

2

1 reference

6 August 2017

135-142

1 reference

6 August 2017

The tularaemia vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Live vaccine strain of Francisella tularensis: infection and immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

The requirement for gamma interferon in resistance of mice to experimental tularemia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

The identification of five genetic loci of Francisella novicida associated with intracellular growth

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

MglA and MglB are required for the intramacrophage growth of Francisella novicida

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Influence of the bcg locus on natural resistance to primary infection with the facultative intracellular bacterium Francisella tularensis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of th

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2900084-9

7 January 2021

10.1016/S1286-4579(02)00084-9

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12650771